4.5 Review

Protein disulfide isomerases in neurodegeneration: From disease mechanisms to biomedical applications

期刊

FEBS LETTERS
卷 586, 期 18, 页码 2826-2834

出版社

WILEY
DOI: 10.1016/j.febslet.2012.07.023

关键词

Neurodegenerative disease; Protein disulfide isomerase; Protein misfolding; Endoplasmic reticulum stress; Protein quality control

资金

  1. Muscular Dystrophy Association and ALS Therapy Alliance
  2. FONDECYT [1100176]
  3. postdoctoral FONDECYT fellowship [3110067]
  4. FONDAP Grant [15010006]
  5. Millennium Institute [P09-015-F]
  6. Ring Initiative Act [1109]
  7. Alzheimer Association
  8. North American Spine Society
  9. Michael J. Fox Foundation for Parkinson research
  10. CONICYT
  11. FEBA Foundation PhD fellowships

向作者/读者索取更多资源

Protein disulfide isomerases (PDIs) are a family of foldases and chaperones primarily located at the endoplasmic reticulum that catalyze the formation and isomerization of disulfide bonds thereby facilitating protein folding. PDIs also perform important physiological functions in protein quality control, cell death, and cell signaling. Protein misfolding is involved in the etiology of the most common neurodegenerative diseases, including Alzheimer, Parkinson, amyotrophic lateral sclerosis, Prion-related disorders, among others. Accumulating evidence indicate altered expression of PDIs as a prominent and common feature of these neurodegenerative conditions. Here we overview most recent advances in our understanding of the possible functional contribution of PDIs to neurodegeneration, depicting a complex and poorly understood scenario. Possible therapeutic benefits of targeting PDIs in a disease context and their use as biomarkers are discussed. (c) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据